Journal of Multiple Sclerosis

Articles published in Journal of Multiple Sclerosis have been cited by esteemed scholars and scientists all around the world.

Cavallo, S. (2020). Immune-mediated genesis of multiple sclerosis. Journal of Translational Autoimmunity, 3, 100039.

Katsavos, S., Artemiadis, A., Davaki, P., Stamboulis, E., Kilindireas, K., & Anagnostouli, M. (2018). Familial multiple sclerosis in Greece: Distinct clinical and imaging characteristics in comparison with the sporadic disease. Clinical neurology and neurosurgery, 173, 144-149.

Stamatelos, P., & Anagnostouli, M. (2017). HLA-genotype in multiple sclerosis: the role in disease onset, clinical course, cognitive status and response to treatment: a clear step towards personalized therapeutics. Immunogenet open access, 2(1), 1-12.

Gianfrancesco, M. A., Stridh, P., Shao, X., Rhead, B., Graves, J. S., Chitnis, T., ... & Network of Pediatric Multiple Sclerosis Centers. (2018). Genetic risk factors for pediatric-onset multiple sclerosis. Multiple Sclerosis Journal, 24(14), 1825-1834.

Bruno, A., Ronchey, S., Califano, L., Attanasio, G., Minni, A., Cavazzuti, P. P., ... & Mangialardi, N. 27Chronic cerebrospinal venous insufficiency and Meniere disease.

Kalodimou, V. E. (2014). Multiple Sclerosis & Research. J Mult Scler, 1(107), 2.

Khatri, B. O., Tarima, S., McQuillen, M. P., Kramer, J., & Dukic, M. (2014). Plasma Exchange in Secondary Progressive Multiple Sclerosis.

Andersen, J. B., Wandall-Holm, M. F., Andersen, P. K., Sellebjerg, F., & Magyari, M. (2021). Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort. Multiple Sclerosis Journal, 13524585211057767.

Andersen, J. B., & Magyari, M. (2020). Pharmacotherapeutic considerations in women with multiple sclerosis. Expert Opinion on Pharmacotherapy, 21(13), 1591-1602.

D’Amico, E., Leone, C., & Patti, F. (2016). Offspring number does not influence reaching the disability’s milestones in multiple sclerosis: a seven-year follow-up study. International journal of molecular sciences, 17(2), 234.

Vaughn, C., Bushra, A., Kolb, C., & Weinstock-Guttman, B. (2018). An update on the use of disease-modifying therapy in pregnant patients with multiple sclerosis. CNS drugs, 32(2), 161-178.

Coyle, P. K., Oh, J., Magyari, M., Oreja-Guevara, C., & Houtchens, M. (2019). Management strategies for female patients of reproductive potential with multiple sclerosis: an evidence-based review. Multiple sclerosis and related disorders, 32, 54-63.

Coyle, P. K. (2014). Multiple sclerosis in pregnancy. CONTINUUM: Lifelong Learning in Neurology, 20(1), 42-59.

Sandberg-Wollheim, M., Neudorfer, O., Grinspan, A., Weinstock-Guttman, B., Haas, J., Izquierdo, G., ... & Coyle, P. K. (2018). Pregnancy outcomes from the branded glatiramer acetate pregnancy database. International journal of MS care, 20(1), 9-14.

Motamedi, M. H. K., & Danial, Z. (2014). Journal of Multiple Sclerosis.

Khan M, Zahoor I, Haq EU (2015) Human Immunodeficiency Virus and Multiple Sclerosis Risk: Probing for a Connection. J Mult Scler 2(1000141): 376-0389.

Sánchez Morales C (2017) Alteraciones motoras, cognitivas y emocionales en la encefalomielitis autoinmune experimental.

Ludwig M, Turel AP, Zagon IS, McLaughlin PJ (2016) Take a look at the Recent articles.

Ludwig MD, Turel AP, Zagon IS, McLaughlin PJ (2016) Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis. Multiple Sclerosis Journal–Experimental, Translational and Clinical 2: 2055217316672242.

Ludwig MD, Turel AP, Zagon IS, McLaughlin PJ (2015) Treatment of clinically isolated syndrome and low dose naltrexone. Clin Case Reports Rev 1: 182-184.